Obiettivo Research and development of a new microcapsule contrast agent with unique properties for MRI of both, the blood pool and internal organs. This dual agent approach allows patients to receive quicker and more convenient diagnosis, earlier disease detection and significantly reduces health care spending. The current problem relates to multiple and cost-& time intensive diagnosis - intended to be reduced to a 'one step diagnosis' by this new technology. Within the Craft project (step 2) we expect to develop a contrast agent suitable for the initial stages of clinical testing. Expertise and know-how of the Imaging market is available within the SME consortium. A suitable company (RTD performer) with the required know-how of the microcapsule spray dry technology is already identified. Campo scientifico engineering and technologymedical engineeringdiagnostic imagingmagnetic resonance imaging Programma(i) FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002 Argomento(i) 1.1.1.-3. - Key action The "Cell factory" Invito a presentare proposte Data not available Meccanismo di finanziamento EAW - Exploratory awards Coordinatore GOLDHAM BIOGLAN PHARMA GMBH Contributo UE Nessun dato Indirizzo Am Wasserberg 11 86441 ZUSMARSHAUSEN Germania Mostra sulla mappa Costo totale Nessun dato Partecipanti (1) Classifica in ordine alfabetico Classifica per Contributo UE Espandi tutto Riduci tutto SANOCHEMIA PHARMAZEUTIKA AG Austria Contributo UE Nessun dato Indirizzo Boltzmanng-11 1090 WIEN Mostra sulla mappa Costo totale Nessun dato
